Intranasal epinephrine was administered within 1 minute of identifying the reaction or when the patient returned to the ...
Discover a study examining epinephrine for anaphylaxis safety, highlighting cardiovascular risks, correct dosing, and why ...
Detailed price information for Ars Pharmaceuticals Inc (SPRY-Q) from The Globe and Mail including charting and trades.
A Prescription Drug User Fee Act target date of January 31, 2026 has been set for the application. The Food and Drug Administration (FDA) has accepted the New Drug Application (NDA) for epinephrine ...
"We are executing our commercial strategy across multiple fronts, with each element reinforcing the others to drive momentum,” said Richard Lowenthal, Co-Founder, President and CEO of ARS Pharma. "Our ...